Search for: "Ely Lilly" Results 981 - 1000 of 2,157
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
27 Feb 2020, 8:21 am by Dennis Crouch
Eli Lilly and Company, SCT Docket No. [read post]
23 Mar 2021, 1:35 pm by Tom Lamb
Specifically, besides Xeljanz there are two other JAK inhibitors approved by the FDA: Olumiant (baricitinib) from Eli Lilly & Co.; and, Rinvoq (upadacitinib) from AbbVie. [read post]
9 May 2017, 4:42 am
  Subsequently, the CJEU held in Case C-493/12 Eli Lilly & Co Ltd v Human Genome Sciences Inc [EU: C:2013:835] that Article 3(a) must be interpreted as meaning that it was not necessary for the active ingredient to be identified in the claim by means of a structural formula. [read post]
27 Aug 2018, 4:01 am by SHG
But surprisingly, it also had an op-ed calling out Eli Lilly for taking it too far when dropping Conor Daly. [read post]
9 Aug 2011, 8:24 pm by Eric Schweibenz
’s (collectively, “Teva”) motion to quash and/or limit the subpoenas duces tecum and ad testificandum issued upon application of Complainant Eli Lilly and Company (“Lilly”). [read post]
11 Oct 2018, 12:57 am by Eszter Szakács
Here the court agreed with MSD’s appeal in that the HIPO’s interpretation of the Eli Lilly judgment was wrong: it does not follow from this judgment that the concerned active ingredient should be mentioned by name or by structure in the description. [read post]
3 Apr 2007, 9:54 am
H&H's first such client against pharmaceutical giant Eli Lilly & Co. is the state of New Mexico, which claims it spent about $18 million on Zyprexa-related medical expenses between 1999 and 2005. [read post]
19 Jul 2011, 6:03 am by Mark Zamora
Here's the list for 2011 so far:  Potential Signals of Serious Risks/New Safety Information Identified by AERS, January to March 2011 Product Potential Signal of a Serious Risk/New Safety Information Additional Information (as of May 31, 2011) … [read post]
22 Jan 2010, 12:23 pm by Howard Wasserman
Third, going off something Matt argued: Are businesses (especially large GM/Disney/Eli Lilly types) going to engage in candidate electioneering (as opposed to issue advertising)? [read post]
12 Apr 2008, 3:57 pm
Just to get an idea of how big this issue is, Eli Lilly, who voluntarily started reporting this type of information last year (thank you Eli Lilly), gave almost $19 million in one quarter of 2007 for these "grants" as they refer to them. [read post]
7 Nov 2007, 6:57 pm by Christopher S. Jones
”You can read the Order, dated August 17th, 2007, on Acquirelaw™ at In re Eli Lilly & Co. [read post]
26 Mar 2010, 8:21 am by Lawrence B. Ebert
Eli Lilly, a majority of the en banc Federal Circuit decided to retain both traditional and Lilly written description as distinct requirements of patentability. [read post]
20 Mar 2013, 10:00 pm by Nietzer
., (S&N) Deferred Prosecution Agreement (DPA) for criminal FCPA violations, the Oracle SEC Complaint for books and records violations and the Eli Lilly and Company (Lilly) SEC Compliant for books and records violations. [read post]
7 Sep 2010, 6:10 pm by Kelly
Highlights this week included: CAFC: Disclosure that merely allows PHOSITA to ‘envision’ the claimed invention fails written description: Goeddel v Sugano (Peter Zura’s 271 Patent Blog) (Patently-O) (Patent Prospector) Evista (Raloxifene) – US: CAFC upholds decision against Teva: Eli Lilly & Co v Teva Pharmaceuticals USA, Inc (Patent Docs) (The IP Factor) Aranesp (Darbepoetin) – EU: ECJ says ‘no’ to Kirin Amgen, ‘yes’ to… [read post]
11 Jun 2010, 12:55 pm by Jerome Noll
Another famous Qui-Tam lawsuit was filed by 6 employees of Eli Lilly & Company alleging that Zyprexa was marketed off-label for untested and unapproved uses. [read post]
9 Apr 2007, 7:30 am
Temple said the agency was "not particularly worried" about the drug.Also from this March 30 WSJ article, it seems as if Eli Lilly & Co. disputes this FDA action concerning pergolide products, including Permax:Eli Lilly & Co., which began marketing pergolide in the U.S. in 1989 and still sells it overseas, said it has no plans to pull it from foreign markets. [read post]
10 Apr 2015, 3:00 am by Steve Brachmann
The early months of 2015 have been interesting ones for the pharmaceutical industry, an incredibly valuable industry sector that comes under our focus from time to time here at IPWatchdog. [read post]
14 Feb 2012, 8:25 am
Oral argument argued before the Eighth Circuit U.S. [read post]
2 Apr 2016, 4:00 am by Steve Brachmann
Migraines are the result of a hereditary neurological disorder which causes certain areas of the brain to become over-excited, creating the throbbing pain and increased sensitivity to lights, smells or sounds which characterize a migraine attack. [read post]